BPA Call 36C25921A0036-36C25922N0279
Award Date
5/1/22
Potential Completion Date
4/30/23
Potential Value
$20K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Myriad Genetic Laboratories Inc.
Ultimate Awardee
Myriad Genetics Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84148, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration was granted to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide Prolaris prostate cancer testing services. The firm fixed price contract, valued at $14,994.00, is a Blanket Purchase Agreement (BPA) call to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network (VISN) 19 in Salt Lake...
This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
The Department of Veterans Affairs Veterans Health Administration awarded a $5,984 firm fixed price delivery order to Myriad Genetic Laboratories Inc. for ProLaris testing. The parent company of the prime contractor is Myriad Genetics Inc. The single award was made on December 1, 2021 with a completion date of November 30, 2022. The place of performance is located in Emigration Canyon, Utah. No set aside designation was used for this contract to provide genetic testing services through the VHA's...
This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600...
This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a Blanket Purchase Agreement Call contract to Myriad Genetic Laboratories Inc. for $0.00 potential value. Under the contract, Myriad Genetic Laboratories Inc. will provide Prolaris prostate cancer testing services to the agency through April 30, 2026. As the parent company, Myriad Genetics Inc. will oversee work conducted by Myriad Genetic Laboratories Inc. No set-aside designation...
This is a federal contract award from the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract is for the provision of Prolaris prostate cancer testing services to the VA's Salt Lake City VA Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $2,499. The contract has no set-aside designation. This BPA is part of a larger Indefinite Delivery Vehicle (IDV) awarded by the VA's...
This federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., is for a Firm Fixed Price Purchase Order of $7,946.32 to provide MYRIAD GENETIC TESTING services. The contract, awarded by the Defense Health Agency, has an ultimate completion date of February 25, 2017. Myriad Genetic Laboratories Inc. is a for-profit company that specializes in genetic testing and precision medicine services. The primary service provided under this contract is the Prolaris...
This is a firm-fixed-price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The $95,000.00 contract is for the provision of various genetic testing services, with a focus on Prolaris prostate cancer testing. The contract is a Blanket Purchase Agreement (BPA) call, allowing the Department of Veterans Affairs (VA) to efficiently procure Myriad's specialized genetic testing services across multiple regions....